Understanding OUR Cytokine-Based Immunotherapy Candidates Our determination extends to advancing a robust portfolio of programs directed at expanding the horizons of cytokine-based immunotherapy, especially for cancers where remedy alternatives remain limited. Make use of the links below to learn extra about our portfolio of cytokine-based immunotherapy candidates. Explore Our https://financefeeds.com/asx-appoints-dirk-mcliesh-as-chief-risk-officer/